Please login to the form below

Not currently logged in

Britannia promotes Robert Wood

He takes up new marketing director role

Britannia_Robert_WoodBritannia Pharmaceuticals has promoted Robert Wood to marketing director, for international markets.

Wood was previously director partners, EMEA at Britannia and has 15 years experience in the life science and pharmaceutical industries.

Prior to joining Britannia, which is part of Stada, in early 2011, his roles included business unit director, pharmaceuticals at International SOS and vice president of business development at Optasia Medical.

Britannia Pharmaceuticals has been working in Parkinson's disease for over thirty years and its APO-go product range is licensed in almost 40 countries.

Wood said: “I am delighted to be continuing to work with Britannia Pharmaceuticals in this new global role, particularly at this incredibly interesting time for the APO-go therapy.

“The initiation of clinical trials to increase the evidence base for both motor and non-motor effects of APO-go in Parkinson's disease and the development of new delivery devices, mean APO-go will provide an excellent treatment option for many more people with Parkinson's.”

3rd May 2013

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...